Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience

Abstract Introduction Keratoacanthomas are cutaneous neoplasms known for their rapid growth and spontaneous regression over a long time period. Their treatment can be difficult because of the potentially large field size and number of lesions. Intralesional methotrexate constitutes an effective, non...

Full description

Bibliographic Details
Main Authors: Massimiliano Scalvenzi, Angela Patrì, Claudia Costa, Matteo Megna, Maddalena Napolitano, Gabriella Fabbrocini, Nicola Balato
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-02-01
Series:Dermatology and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s13555-019-0286-1
_version_ 1819051158425042944
author Massimiliano Scalvenzi
Angela Patrì
Claudia Costa
Matteo Megna
Maddalena Napolitano
Gabriella Fabbrocini
Nicola Balato
author_facet Massimiliano Scalvenzi
Angela Patrì
Claudia Costa
Matteo Megna
Maddalena Napolitano
Gabriella Fabbrocini
Nicola Balato
author_sort Massimiliano Scalvenzi
collection DOAJ
description Abstract Introduction Keratoacanthomas are cutaneous neoplasms known for their rapid growth and spontaneous regression over a long time period. Their treatment can be difficult because of the potentially large field size and number of lesions. Intralesional methotrexate constitutes an effective, nonsurgical treatment of keratoacanthomas, as proven by our experience. Methods We treated 11 elderly patients affected by keratoacanthoma with intralesional methotrexate. The injections were performed weekly, followed by 10 mg of folic acid to be taken 24 h later. Results All our patients underwent complete resolution of the lesions after 4–8 injections, without side effects. Conclusion Intralesional methotrexate seems to be an effective and safe nonoperative treatment modality for keratoacanthoma, especially when it arises in anatomic areas difficult to treat with surgery, in elderly debilitated patients, and in those refusing surgery.
first_indexed 2024-12-21T11:59:29Z
format Article
id doaj.art-161dbd69682f4db586bf011bb661c344
institution Directory Open Access Journal
issn 2193-8210
2190-9172
language English
last_indexed 2024-12-21T11:59:29Z
publishDate 2019-02-01
publisher Adis, Springer Healthcare
record_format Article
series Dermatology and Therapy
spelling doaj.art-161dbd69682f4db586bf011bb661c3442022-12-21T19:04:51ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722019-02-019236937210.1007/s13555-019-0286-1Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan ExperienceMassimiliano Scalvenzi0Angela Patrì1Claudia Costa2Matteo Megna3Maddalena Napolitano4Gabriella Fabbrocini5Nicola Balato6Department of Dermatology, University of Naples Federico IIDepartment of Dermatology, University of Naples Federico IIDepartment of Dermatology, University of Naples Federico IIDepartment of Dermatology, University of Naples Federico IIDepartment of Medicine and Health Sciences Vincenzo Tiberio, University of MoliseDepartment of Dermatology, University of Naples Federico IIDepartment of Dermatology, University of Naples Federico IIAbstract Introduction Keratoacanthomas are cutaneous neoplasms known for their rapid growth and spontaneous regression over a long time period. Their treatment can be difficult because of the potentially large field size and number of lesions. Intralesional methotrexate constitutes an effective, nonsurgical treatment of keratoacanthomas, as proven by our experience. Methods We treated 11 elderly patients affected by keratoacanthoma with intralesional methotrexate. The injections were performed weekly, followed by 10 mg of folic acid to be taken 24 h later. Results All our patients underwent complete resolution of the lesions after 4–8 injections, without side effects. Conclusion Intralesional methotrexate seems to be an effective and safe nonoperative treatment modality for keratoacanthoma, especially when it arises in anatomic areas difficult to treat with surgery, in elderly debilitated patients, and in those refusing surgery.http://link.springer.com/article/10.1007/s13555-019-0286-1KeratoacanthomaMethotrexateNonsurgical treatment
spellingShingle Massimiliano Scalvenzi
Angela Patrì
Claudia Costa
Matteo Megna
Maddalena Napolitano
Gabriella Fabbrocini
Nicola Balato
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
Dermatology and Therapy
Keratoacanthoma
Methotrexate
Nonsurgical treatment
title Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
title_full Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
title_fullStr Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
title_full_unstemmed Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
title_short Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
title_sort intralesional methotrexate for the treatment of keratoacanthoma the neapolitan experience
topic Keratoacanthoma
Methotrexate
Nonsurgical treatment
url http://link.springer.com/article/10.1007/s13555-019-0286-1
work_keys_str_mv AT massimilianoscalvenzi intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT angelapatri intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT claudiacosta intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT matteomegna intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT maddalenanapolitano intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT gabriellafabbrocini intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience
AT nicolabalato intralesionalmethotrexateforthetreatmentofkeratoacanthomatheneapolitanexperience